Table 4 Diabetic Cohort (n = 1,656) Clinical and Demographic Characteristics by BP Control Status
Uncontrolled BP (n = 1,105) | Controlled BP (<130/80 mmHg) (n = 551) | Total (N = 1,656) | |
|---|---|---|---|
Age (years; mean, SD) | 64.8 (12.3) | 66.8 (12.0) (p < 0.01) | 65.4 (12.2) |
Gender- Male (n,%) | 542 (65.5%) | 286 (34.5%) | 828 (50.6%) |
Female (n,%) | 549 (67.9%) | 259 (32.1%) (p=NS) | 808 (49.4%) |
BMI (kg/m2; mean, SD) | 33.5 (7.5) | 32.7 (7.8) (p < 0.05) | 33.2 (7.6) |
Normal (n,%) | 118 (59.9%) | 79 (40.1%) | 197 (11.9%) |
Overweight (n,%) | 276 (66.2%) | 141 (33.8%) | 417 (25.2%) |
Obese (n,%) | 521 (68.1%) | 244 (31.9%) | 765 (46.2%) |
Morbidly obese (n,%) | 190 (68.6%) | 87 (31.4%) | 277 (16.7%) |
Racial/ethnic background (n,%) | (p < 0.001) | ||
Caucasian | 452 (60.6%) | 294 (39.4%) | 746 (45.0%) |
African-American | 211 (78.7%) | 57 (21.3%) | 268 (16.2%) |
Hispanic | 112 (71.8%) | 44 (28.2%) | 156 (9.4%) |
Unknown/not documented | 330 (67.9%) | 156 (32.1%) | 486 (29.3%) |
Prescribed lifestyle modifications to control BP (%) | 706 (64.8%) | 353 (65.0%) | 1059(64.8%) |
Number of antihypertensive medications (mean, SD) | 2.2 (1.2) | 2.3 (1.2) (p=NS) | 2.3 (1.2) |
Number of chronic medications (mean, SD) | 7.1 (3.6) | 8.1 (4.0) (p < 0.001) | 7.4 (3.8) |
Antihypertensive medication class | Use among uncontrolled patients (n = 1,105) | Use among controlled patients (n = 551) | Use among all patients (n = 1,656) |
ACEI/ARB | 75.7% | 81.7% (p < 0.02) | 78.3% |
BB | 39.7% | 43.6% (p=NS) | 41.0% |
CCB | 33.4% | 26.1% (p < 0.01) | 31.0% |
Any diuretic | 50.6% | 55.4% (p=NS) | 52.2% |
% with BP control among patients with condition | % with BP control among patients without condition | ||
Hyperlipidemia (%) | 35.1% | 27.8% (p = 0.006) | |
Renal disease/insufficiency (%) | 46.7% | 31.4% (p < 0.001) | |
CAD without MI (%) | 38.4% | 32.1% (p < 0.04) | |
ACEI and/or ARB use (%) | 34.7% | 28.1% (p < 0.03) |